1-1 of 1
Pamela Blair Allen
Close
Sort by
Journal Articles

Evidence-Based Minireview: What is the optimal timing of anti–PD-1 antibodies in relapsed classical Hodgkin lymphoma?

Pamela Blair Allen, Ann S. LaCasce
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 249–251.
https://doi.org/10.1182/hematology.2019000077
Published: 2019